Aug. 30 at 2:13 AM
$NVAX $BCTX So I own both . If you want to talk about a true "Holy Grail" combination for cold, metastatic solid tumors, pairing Bctx platform with matrix m is a flawless theoretical match. Right now, Bria-IMT relies entirely on its engineered GM-CSF to stir up an immune response. While GM-CSF is excellent at recruiting dendritic cells, it does not completely solve the intracellular processing bottlenecks . Integrating matrix m into the Bria injection would create a synergistic effect. BriaCell’s whole cell vaccine presents a massive array of native breast cancer antigens. Injecting matrix m alongside it would trigger immediate Lysosomal MembranePermeabilization inside the newly recruited dendritic cells. Instead of the breast cancer antigens getting stuck or degraded within cellular compartments, the matrix m would force those endosomes to pop. This unloads bctx pre-packaged tumor markers directly into the cell's cytoplasm, resulting in a massive generation of cd8+ killer T cells.
